Acrobiosystems for English
icon_bulk_orderBulk inquiry/Quick order
user
  1. Dashboard
  2. My Profile
  3. My Address
  4. My Orders
  5. Acro Membership
Login Register
Promotion
Recombinant Proteins ClearClear history
Recombinant Proteins CloseClose
Browse Products By Molecule Name a-zA-Z
TL1A Hot |GMP Cytokines Hot |FcRn Binding Kit (TR-FRET) New |Claudin 18.2
0
There is no goods in the shopping cart !
My Cart|Secure Checkout
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z 0-9
Your Position: Home > EDNRA

EDNRA

Brief Information

Name:Endothelin receptor type A
Target Synonym:Endothelin Receptor Type A,EDNRA,ETA-R,Endothelin-1 receptor,hET-AR,ETRA,ET-A,ETA,Endothelin-1-Specific Receptor,Endothelin Receptor Subtype A,G Protein-Coupled Receptor,ETAR,MFDA,Receptor, Endothelin A
Number of Launched Drugs:7
Number of Drugs in Clinical Trials:9
Lastest Research Phase:Approved

Product ListCompare or Buy

Product> Filter Results
By Product Status:
By Product Category:
By Species:
By Conjugate:
Cat. No. Species Product Description Structure Purity Feature
EDA-H52P8 Human Human EDNRA Full Length Protein (VLP)
ACRO Quality

Part of Bioactivity data

EDA-H52P8-ELISA
EDNRA ELISA

Immobilized Human EDNRA Full Length Protein-VLP (Cat. No. EDA-H52P8) at 2 μg/mL (100 μL/well) can bind Monoclonal Anti-Human EDNRA antibody, Human IgG1 with a linear range of 0.1-8 ng/mL (QC tested).

Protocol

Public Drug Information

Name Research Code Research Phase Company First Brand Name First Approved Country First Indication First Approved Company First Approved Date Indications Clinical Trials
Clazosentan Sodium Ro-61-1790; ACT-108475; AXV-034; VML-588; AXV-034343 Approved F. Hoffmann-La Roche Ltd Pivlaz Japan Subarachnoid Hemorrhage; Brain Ischemia; Vasospasm, Intracranial; Cerebral Infarction Idorsia Pharmaceuticals Ltd 2022-01-20 Brain Ischemia; Aneurysm; Vasospasm, Intracranial; Subarachnoid Hemorrhage; Cerebral Infarction Details
Macitentan/Tadalafil Approved Actelion Pharmaceuticals Ltd OPSYNVI, Yuvanci United States Pulmonary Arterial Hypertension Actelion Pharmaceuticals Us Inc 2024-03-22 Phenylketonurias; Pulmonary Arterial Hypertension Details
Ambrisentan LU-208075; BSF-208075; GSK-132576A Approved Abbott Laboratories Letairis, Volibris, 凡瑞克 United States Pulmonary Arterial Hypertension Gilead Sciences Inc 2007-06-15 Hypertension, Pulmonary; Sarcoidosis; Hypertension, Portal; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Coronavirus Disease 2019 (COVID-19); Liver Cirrhosis; Thromboembolism; Hypertension; Ascites; Hypoxia; Acute Kidney Injury; Pulmonary Arterial Hypertension; Vascular Diseases; Anemia, Sickle Cell; Hepatorenal Syndrome Details
Sparsentan BMS-346567; RE-021; PS-433540 Approved Bristol-Myers Squibb Company Filspari United States Glomerulonephritis, IGA Travere Therapeutics Inc 2023-02-17 Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Glomerulonephritis, IGA; Autoimmune Diseases; Kidney Diseases; Vasculitis; Nephrosis, Lipoid; Hypertension; Immune System Diseases; Glomerulosclerosis, Focal Segmental; Cardiovascular Diseases; Glomerulonephritis; Nephritis, Hereditary Details
Bosentan Hydrate ACT-050088; HGP-1206; Ro-47-0203; Ro-47-0203/029; Ro-47-0203/039 Approved F. Hoffmann-La Roche Ltd Stayveer, 全可利, Tracleer United States Pulmonary Arterial Hypertension Actelion Pharmaceuticals Ltd 2001-11-20 Hepatopulmonary Syndrome; Diabetes Mellitus; Heart Defects, Congenital; Anemia, Sickle Cell; Persistent Fetal Circulation Syndrome; Ulcer; Glaucoma; Sleep Apnea Syndromes; Pulmonary Arterial Hypertension; Coronary Vasospasm; Lung Diseases, Interstitial; Hypertension, Pulmonary; Pulmonary Fibrosis; Hypertension; Fibrosis; Chronic thromboembolic pulmonary hypertension; Liver Cirrhosis; Sarcoidosis; Scleroderma, Systemic; Idiopathic Pulmonary Fibrosis; Diabetes Mellitus, Type 2; Heart Septal Defects, Atrial Details
Macitentan ACT-064992; Actelion-1; JNJ-67896062 Approved Actelion Pharmaceuticals Ltd Zependo, Opsumit, 傲朴舒 United States Pulmonary Arterial Hypertension Actelion Pharmaceuticals Us Inc 2013-10-18 Hypertension, Pulmonary; Pulmonary Embolism; Heart Failure, Diastolic; Heart Failure; Scleroderma, Systemic; Chronic thromboembolic pulmonary hypertension; Idiopathic Pulmonary Fibrosis; Glioblastoma; Thromboembolism; Pulmonary Arterial Hypertension; Eisenmenger Complex; Scleroderma-associated interstitial lung diseases; Ulcer; Heart Defects, Congenital; Anemia, Sickle Cell; Chronic Disease Details
Aprocitentan JNJ-2820; ACT-132577; AC-080 Approved Actelion Pharmaceuticals Ltd, Idorsia Pharmaceuticals Ltd TRYVIO, JERAYGO United States Hypertension Idorsia Pharmaceuticals Ltd 2024-03-19 Hypertension; Essential Hypertension; Hepatic Insufficiency; Renal Insufficiency, Chronic Details

Clinical Drug Information

Name Research Code Research Phase Company Indications Clinical Trials
SC-0062 SC-0062 Phase 3 Clinical Shijiazhuang Zhikang Hongren New Drug Development Co Ltd Glomerulonephritis, IGA; Kidney Diseases; Altitude Sickness; Pulmonary Arterial Hypertension; Diabetic Nephropathies Details
Zibotentan/Dapagliflozin Phase 3 Clinical Astrazeneca Ab, AstraZeneca global R & D (China) Co Ltd Albuminuria; Kidney Diseases; Renal Insufficiency, Chronic Details
Patecibart GMA-301; GMA-301-A; GMA-301-B Phase 2 Clinical Gmax Biopharm Llc Pulmonary Arterial Hypertension Details
Zibotentan ZD-4054; AZD-4054 Phase 2 Clinical Astrazeneca Plc Hepatic Insufficiency; Neoplasm Metastasis; Scleroderma, Limited; Carcinoma, Non-Small-Cell Lung; Peripheral Arterial Disease; Metastatic breast cancer; Lung Neoplasms; Renal Insufficiency, Chronic; Colorectal Neoplasms; Ovarian Neoplasms; Prostatic Neoplasms; Scleroderma, Systemic; Hypertension, Portal; Liver Cirrhosis; Intermittent Claudication; Renal Insufficiency; Microvascular Angina; Solid tumours Details
SAL-0120 SAL-0120; SAL0120 Phase 2 Clinical Shenzhen Salubris Pharmaceuticals Co Ltd Glomerulonephritis, IGA; Hypertension; Essential Hypertension; Renal Insufficiency, Chronic Details
HS-10390 HS-10390; HS10390 Phase 2 Clinical Changzhou Hengbang Pharmaceutical Co Ltd, Shanghai Hansoh Biomedical Co Ltd Glomerulonephritis, IGA; Glomerulosclerosis, Focal Segmental Details
BQ-123 CGS-26343; BQ-123; PMZ-2123 Phase 1 Clinical Midwestern University Hypertension, Pulmonary; Pain; Diabetic Ketoacidosis; ST Elevation Myocardial Infarction; Heart Failure; Hypoxia, Brain; Coronary Artery Disease; Proteinuria; Metabolic Syndrome; Hypertension; Cardiovascular Diseases; Renal Insufficiency, Chronic; Pure Autonomic Failure; Multiple System Atrophy Details
GMA-131 GMA-131 Phase 1 Clinical Gmax Biopharm Llc, Gmaxx Biologics Ltd Diabetic Nephropathies Details

This web search service is supported by Google Inc.

totop
Call us
Call us
North America:
+1 800-810-0816 (Toll Free)
Asia & Pacific:
+86 400-682-2521
Email
Email
order@acrobiosystems.com
Fax
Fax
+1 888-377-6111
Address
Address
1 Innovation Way, Newark, DE 19711, USA
linkedin twitter facebook youtube

Leave a message

Copyright © 2017 ACROBiosystems. All Rights Reserved
|Related Links|Privacy Policy|Terms and Conditions|Legal|Sitemap